More on CATX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Perspective Therapeutics (NY:CATX)
Delayed: 2.95 -0.03 (1.01%)
Prev. Close $2.98  
Open$3.02 
52 Wk High$ 
52 Wk Low$ 
Day High$3.13 
Day Low$2.93 
P/E N/A  
EPS$ 
Volume7,664,663 

Friends, Peers and Foes (?): BCYC, IDYA, ACAD, BCRX, CDTX (more...)

Jun 1, 2026 06:31 AM Form 8-K Perspective Therapeutics For: Jun 01
May 27, 2026 04:20 PM Form 8-K Perspective Therapeutics For: May 27
May 22, 2026 06:01 AM Form 8-K Perspective Therapeutics For: May 21
May 21, 2026 05:51 PM Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
May 18, 2026 06:30 AM Perspective Therapeutics doses first patients in new study cohorts
May 18, 2026 06:30 AM Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies
May 12, 2026 12:48 PM Form SCHEDULE 13G/A Perspective Therapeutics Filed by: MORGAN STANLEY
May 12, 2026 08:28 AM RBC Capital on Perspective Therapeutics (CATX): 'We see significant upside potential for investors with patience'
May 11, 2026 04:14 PM Form 10-Q Perspective Therapeutics For: Mar 31
May 11, 2026 04:12 PM Form 8-K Perspective Therapeutics For: May 11
View All Articles

Entities mentioned with CATX

View All Entities